Purchase Order HHSN272201701066P

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $12,928.46 on August 15, 2017, for RNA kits, beads, and processor equipment on a firm fixed price basis. Work is performed in Hamilton, Montana, with an ultimate completion date of September 1, 2017.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for RNA, PCR, and plasmid kits valued at $13,517.30 on June 21, 2017, with ultimate completion on June 26, 2017. Place of performance is Hamilton, Montana. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $5,947.89 on January 3, 2018, with ultimate completion on January 28, 2018. The order procures HOTSTARTAQ PLUS DNA Polymerase (5,000 units, catalog #203607) under firm fixed price terms. Place of performance is Valencia, California.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a purchase order to Qiagen, LLC for $13,936.53 on July 5, 2017, with an ultimate completion date of July 14, 2017.</p> <p>The order procures QIAGEN reagent kits for delivery to Hamilton, Montana. The purchase order carries no set-aside designation and employs firm fixed price terms.</p>

The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded a $4,094.11 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. This award does not have a set-aside designation. The award supports Qiagen's provision of products and services to NIAID, such as DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and bioinformatics...

The National Institute of Allergy and Infectious Diseases awarded a $17,013.02 firm fixed-price purchase order to Qiagen, LLC for the QIASEQ FastSelect 5S/16S/23S Kit (384). This contract, awarded on September 16, 2021, with an ultimate completion date of September 24, 2021, represents a straightforward procurement of specialized molecular biology reagents used for ribosomal RNA depletion and sample preparation in next-generation sequencing applications. The award includes no set-aside...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $10,736.64 on August 11, 2020. The order covers ten HISPEED Plasmid Maxi Kits at $252.00 each, priced on a firm fixed-price basis. Work is performed in Germantown, Maryland, with an ultimate completion date of September 6, 2020. No small business set-aside applies.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $13,936.20 in QIAcube-compatible QIAseq sequencing kits on September 13, 2021, with ultimate completion on July 7, 2022. The order was issued to de-obligate unexpiring fiscal year 2021 funds in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 period-of-availability close. Performance takes place in Germantown, Maryland. The purchase order carries firm fixed price pricing...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $17,478.36 on November 7, 2018, for HotStartAQ Plus DNA Polymerase (catalog number 203609, quantity 25,000 units) under firm fixed-price pricing. Work is performed in Valencia, California. The order is not set-aside and carries an ultimate completion date of November 25, 2018.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for an annual service agreement for nucleic acid extraction equipment, valued at $10,410.00, with an award date of May 15, 2020 and completion date of May 14, 2021. Work is performed in Germantown, Maryland. The order is priced on a firm fixed price basis with no set-aside designation.</p>